Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

BUY
$25.26 - $29.6 $1.12 Million - $1.31 Million
44,400 New
44,400 $1.24 Million
Q1 2023

May 05, 2023

BUY
$39.39 - $51.28 $834,398 - $1.09 Million
21,183 New
21,183 $864,000
Q3 2022

Oct 25, 2022

BUY
$43.76 - $53.42 $823,738 - $1.01 Million
18,824 Added 27.6%
87,024 $3.81 Million
Q2 2022

Jul 27, 2022

BUY
$46.53 - $55.17 $1.19 Million - $1.41 Million
25,500 Added 59.72%
68,200 $3.58 Million
Q1 2022

May 04, 2022

BUY
$45.75 - $56.69 $457,500 - $566,900
10,000 Added 30.58%
42,700 $2.21 Million
Q4 2021

Feb 08, 2022

SELL
$41.32 - $61.25 $1.1 Million - $1.64 Million
-26,700 Reduced 44.95%
32,700 $1.93 Million
Q3 2021

Nov 04, 2021

SELL
$39.25 - $50.42 $628,000 - $806,720
-16,000 Reduced 21.22%
59,400 $2.56 Million
Q2 2021

Jul 27, 2021

BUY
$35.91 - $40.68 $1.69 Million - $1.92 Million
47,200 Added 167.38%
75,400 $2.95 Million
Q1 2021

May 10, 2021

BUY
$33.49 - $37.77 $944,418 - $1.07 Million
28,200 New
28,200 $1.02 Million
Q4 2020

Feb 10, 2021

SELL
$33.47 - $42.56 $960,589 - $1.22 Million
-28,700 Closed
0 $0
Q3 2020

Nov 03, 2020

BUY
$31.75 - $37.25 $590,550 - $692,850
18,600 Added 184.16%
28,700 $1.05 Million
Q2 2020

Jul 30, 2020

BUY
$30.12 - $36.54 $304,212 - $369,054
10,100 New
10,100 $330,000
Q1 2019

May 09, 2019

SELL
$37.5 - $41.2 $546,525 - $600,448
-14,574 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$38.47 - $43.86 $52,857 - $60,263
1,374 Added 10.41%
14,574 $636,000
Q3 2018

Oct 25, 2018

BUY
$34.47 - $41.81 $455,004 - $551,892
13,200 New
13,200 $582,000
Q4 2017

Feb 09, 2018

SELL
$33.26 - $35.29 $188,351 - $199,847
-5,663 Closed
0 $0
Q3 2017

Oct 30, 2017

BUY
$31.0 - $34.15 $175,553 - $193,391
5,663
5,663 $202,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Versor Investments LP Portfolio

Follow Versor Investments LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versor Investments LP, based on Form 13F filings with the SEC.

News

Stay updated on Versor Investments LP with notifications on news.